ENM3/V/33/Antineuropatho/2023, Agreement signed on: 30.08.2023

NanoSanguis S.A. is implementing the project titled “Developing Novel Nanopharmaceutics Against Bacterial Infections in the Central Nervous System” (ANTINEUROPATHO).

The project is carried out within a European consortium.

The goal of the project is to develop nanosystems capable of crossing the blood-brain barrier while simultaneously delivering a novel antibacterial agent.

Project value: PLN 1,038,642.08
Funding amount: PLN 830,913.66
Project duration: 01.07.2023 – 30.06.2026

The project is co-financed by the National Centre for Research and Development (NCBR) under the EuroNanoMed III Joint Transnational Call for Proposals (2021) for “European Innovative Research & Technological Development Projects in Nanomedicine.”